Literature DB >> 29066063

Formation of the Protein Corona: The Interface between Nanoparticles and the Immune System.

Francesco Barbero1, Lorenzo Russo1, Michele Vitali2, Jordi Piella1, Ignacio Salvo3, Mireya L Borrajo3, Marti Busquets-Fité4, Rita Grandori5, Neus G Bastús6, Eudald Casals7, Victor Puntes8.   

Abstract

The interaction of inorganic nanoparticles and many biological fluids often withstands the formation of a Protein Corona enveloping the nanoparticle. This Protein Corona provides the biological identity to the nanoparticle that the immune system will detect. The formation of this Protein Corona depends not only on the composition of the nanoparticle, its size, shape, surface state and exposure time, but also on the type of media, nanoparticle to protein ratio and the presence of ions and other molecular species that interfere in the interaction between proteins and nanoparticles. This has important implications on immune safety, biocompatibility and the use of nanoparticles in medicine.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Keywords:  Homo and Hetero-aggregation; Immune Response; Inorganic Nanoparticles; Nanoparticle-Protein Corona; Protein Corona Characterization; Vroman Effect

Mesh:

Substances:

Year:  2017        PMID: 29066063     DOI: 10.1016/j.smim.2017.10.001

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  47 in total

1.  Nanotechnology for the Development of Nanovaccines in Cancer Immunotherapy.

Authors:  Maria Aurora Grimaudo
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Systemic Bioequivalence Is Unlikely to Equal Target Site Bioequivalence for Nanotechnology Oncologic Products.

Authors:  Jessie L-S Au; Ze Lu; Roberto A Abbiati; M Guillaume Wientjes
Journal:  AAPS J       Date:  2019-02-01       Impact factor: 4.009

Review 3.  Unintended effects of drug carriers: Big issues of small particles.

Authors:  Hamideh Parhiz; Makan Khoshnejad; Jacob W Myerson; Elizabeth Hood; Priyal N Patel; Jacob S Brenner; Vladimir R Muzykantov
Journal:  Adv Drug Deliv Rev       Date:  2018-07-03       Impact factor: 15.470

Review 4.  Target Site Delivery and Residence of Nanomedicines: Application of Quantitative Systems Pharmacology.

Authors:  Jessie L-S Au; Roberto A Abbiati; M Guillaume Wientjes; Ze Lu
Journal:  Pharmacol Rev       Date:  2019-04       Impact factor: 25.468

5.  Modeling Nanocarrier Transport across a 3D In Vitro Human Blood-Brain-Barrier Microvasculature.

Authors:  Sharon Wei Ling Lee; Marco Campisi; Tatsuya Osaki; Luca Possenti; Clara Mattu; Giulia Adriani; Roger Dale Kamm; Valeria Chiono
Journal:  Adv Healthc Mater       Date:  2020-03-03       Impact factor: 9.933

Review 6.  Recent advances in the protective role of metallic nanoparticles in red blood cells.

Authors:  Somu Yadav; Pawan Kumar Maurya
Journal:  3 Biotech       Date:  2021-12-27       Impact factor: 2.406

Review 7.  Cationic Nanoparticle-Based Cancer Vaccines.

Authors:  Jeroen Heuts; Wim Jiskoot; Ferry Ossendorp; Koen van der Maaden
Journal:  Pharmaceutics       Date:  2021-04-21       Impact factor: 6.321

8.  Gemini Cationic Lipid-Type Nanovectors Suitable for the Transfection of Therapeutic Plasmid DNA Encoding for Pro-Inflammatory Cytokine Interleukin-12.

Authors:  Natalia Sánchez-Arribas; María Martínez-Negro; Clara Aicart-Ramos; Conchita Tros de Ilarduya; Emilio Aicart; Andrés Guerrero-Martínez; Elena Junquera
Journal:  Pharmaceutics       Date:  2021-05-15       Impact factor: 6.321

9.  From blood to brain: blood cell-based biomimetic drug delivery systems.

Authors:  Yong-Jiang Li; Jun-Yong Wu; Jihua Liu; Xiaohan Qiu; Wenjie Xu; Tiantian Tang; Da-Xiong Xiang
Journal:  Drug Deliv       Date:  2021-06-18       Impact factor: 6.819

Review 10.  Cross-Species Comparisons of Nanoparticle Interactions with Innate Immune Systems: A Methodological Review.

Authors:  Benjamin J Swartzwelter; Craig Mayall; Andi Alijagic; Francesco Barbero; Eleonora Ferrari; Szabolcs Hernadi; Sara Michelini; Natividad Isabel Navarro Pacheco; Alessandra Prinelli; Elmer Swart; Manon Auguste
Journal:  Nanomaterials (Basel)       Date:  2021-06-09       Impact factor: 5.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.